2 ms·
Considering the fine American tradition (dramatically amplified in the last decade) of underfunding every important regulatory agency and then hollowing it out
by kevingadd 7y ago
Considering the fine American tradition (dramatically amplified in the last decade) of underfunding every important regulatory agency and then hollowing it out through other methods, it doesn't seem very surprising that the FDA is bad at checking products. Hard to imagine closing offices because of "regulatory capture", if anything the big US companies would want more enforcement on foreign generic drug manufacturers to secure their hold on the market.
- Scoundreller 7y agoDunno how much the US FDA is to blame here: these API plants pretty much supply the world with generics. If anything, it's the FDA that's doing foreign plant inspections and every other country's regulator just does what the FDA does. My real question is: Why is each country doing its own inspections? Why not one global inspection? Everyone else is getting a free ride from the FDA's work.